Yahoo
Tokyo - Delayed Quote JPY

Qol Holdings Co., Ltd. (3034.T)

2,436.00 -90.00 (-3.56%)
At close: November 6 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 3034.T
  • Previous Close 2,526.00
  • Open 2,360.00
  • Bid 2,435.00 x --
  • Ask 2,460.00 x --
  • Day's Range 2,289.00 - 2,480.00
  • 52 Week Range 1,681.00 - 2,655.00
  • Volume 224,600
  • Avg. Volume 157,462
  • Market Cap (intraday) 91.539B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 10.67
  • EPS (TTM) 228.35
  • Earnings Date (est.) --
  • Forward Dividend & Yield 64.00 (2.63%)
  • 1y Target Est 2,400.00
  • Moby Rating Neutral

Qol Holdings Co., Ltd., together with its subsidiaries, engages in the pharmacy, BPO, and pharmaceutical businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also provides contract MR staffing; clinical research and development support services in the areas of food and pharmaceuticals; education and training services; and dispatch clinical research associates to support clinical trials. In addition, the company produces sales promotion materials for pharmaceuticals, as well as pamphlets and websites for medical institutions. Further, it engages in pharmaceutical manufacturing business; medical professional referral and dispatch business for the business areas, including pharmacist, medical clerical work, dispensing work, occupational physician, health nurse, nurse, and registered sales clerk; and business succession, health, and productivity management consulting business. The company was formerly known as Qol Co., Ltd. and changed its name to Qol Holdings Co., Ltd. in October 2018. The company was founded in 1992 and is headquartered in Tokyo, Japan.

www.qolhd.co.jp

6,247

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

3034.T
17.13%
Nikkei 225 (^N225)
14.09%

1-Year Return

3034.T
27.50%
Nikkei 225 (^N225)
12.87%

3-Year Return

3034.T
68.57%
Nikkei 225 (^N225)
75.60%

5-Year Return

3034.T
54.14%
Nikkei 225 (^N225)
93.96%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 71.9B
Earnings 1.67B
Profit Margin 2.33%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
20B
40B
60B
2.0%
2.5%
3.0%
3.5%
4.0%

Analyst Insights

View More

Analyst Price Targets

2,400.00 Low
2,400.00 Average
2,436.00 Current
2,400.00

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.90%

  • Return on Assets (ttm)

    7.18%

  • Return on Equity (ttm)

    16.97%

  • Revenue (ttm)

    294.35B

  • Net Income Avi to Common (ttm)

    8.54B

  • Diluted EPS (ttm)

    228.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.65B

  • Total Debt/Equity (mrq)

    58.72%

  • Levered Free Cash Flow (ttm)

    11.42B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: